Skip to main content

Inefficient Clearance of Dying Cells and Autoreactivity

  • Chapter
Current Concepts in Autoimmunity and Chronic Inflammation

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 305))

Abstract

Dying cells were basically unnoticed by scientists for a long time and only came back into the spotlight roughly 10 years ago. The process of recognition and uptake of apoptotic and necrotic cells is complex and failures in this process can contribute to the pathogenesis of autoimmune diseases such as systemic lupus erythematosus (SLE). Here, we discuss the recognition and uptake molecules which are involved in an efficient clearance of dying cells in early and late phases of cell death. The exposure of phosphatidylserine (PS) is an early surface change of apoptosing cells recognized by several receptors and adaptor molecules. We demonstrated that dying cells have cell membranes with high lateral mobility of PS, which contribute to their efficient clearance. Changes of the glycoprotein composition of apoptotic cells occur later than the exposure of PS. We further observed that complement binding is an early event in necrosis and a rather late event in apoptosis. Complement, C-reactive protein (CRP), and serum DNase I act as back-up molecules in the clearance process. Finally, we discuss how the accumulation of secondary necrotic cells and cellular debris in the germinal centers of secondary lymphorgans can lead toautoimmunity. It is reasonable to argue that clearance defects are major players in the development of autoimmune diseases such as SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Appelt U, Sheriff A, Gaipl US, Kalden JR, Voll RE, Herrmann M (2005) Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand annexin V to dying but not viable cells and implications for PS-dependent clearance. Cell Death Differ 12:194–196

    Article  PubMed  CAS  Google Scholar 

  2. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46:191–201

    Article  PubMed  Google Scholar 

  3. Bell SA, Faust H, Schmid A, Meurer M (1998) Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol 113:327–332

    Article  PubMed  CAS  Google Scholar 

  4. Berden JH, Licht R, van Bruggen MC, Tax WJ (1999) Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr Opin Nephrol Hypertens 8:299–306

    Article  PubMed  CAS  Google Scholar 

  5. Bharadwaj D, Mold C, Markham E, Du Clos TW (2001) Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. J Immunol 166:6735–6741

    PubMed  CAS  Google Scholar 

  6. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, Mitchell DA, Cook HT, Butler PJ, Walport MJ, Pepys MB (1999) Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 5:694–697

    Article  PubMed  CAS  Google Scholar 

  7. Bondanza A, Zimmermann VS, Rovere-Querini P, Turnay J, Dumitriu IE, Stach CM, Voll RE, Gaipl US, Bertling W, Poschl E, Kalden JR, Manfredi AA, Herrmann M (2004) Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med 200:1157–1165

    Article  PubMed  CAS  Google Scholar 

  8. Bose J, Gruber AD, Helming L, Schiebe S, Wegener I, Hafner M, Beales M, Kontgen F, Lengeling A (2004) The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J Biol 3:15

    Article  PubMed  Google Scholar 

  9. Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56–59

    PubMed  CAS  Google Scholar 

  10. Botto M (2001) Links between complement deficiency and apoptosis. Arthritis Res 3:207–210

    Article  PubMed  CAS  Google Scholar 

  11. Callahan MK, Williamson P, Schlegel RA (2000) Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic thymocytes. Cell Death Differ 7:645–653

    Article  PubMed  CAS  Google Scholar 

  12. Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A (1999) Cleavage by granzyme B is stronglypredictiveof autoantigenstatus: implications for initiation of autoimmunity. J Exp Med 190:815–826

    Article  PubMed  CAS  Google Scholar 

  13. Chionna A, Panzarini E, Pagliara P, De Luca A, Caforio S, Abbro L, Dini L (2003) Hepatic clearance of apoptotic lymphocytes: simply removal of waste cells? Eur J Histochem 47:97–104

    PubMed  CAS  Google Scholar 

  14. Chitrabamrung S, Rubin RL, Tan EM (1981) Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1:55–60

    Article  PubMed  CAS  Google Scholar 

  15. Di Virgilio F, Borea PA, Illes P (2001) P2 receptors meet the immune system. Trends Pharmacol Sci 22:5–7

    Article  PubMed  Google Scholar 

  16. Dillon SR, Mancini M, Rosen A, Schlissel MS (2000) Annexin V binds to viable B cells and colocalizes with amarker of lipid rafts upon B cell receptor activation. J Immunol 164:1322–1332

    PubMed  CAS  Google Scholar 

  17. Dillon SR, Constantinescu A, Schlissel MS (2001) Annexin V binds to positively selected B cells [In Process Citation]. J Immunol 166:58–71

    PubMed  CAS  Google Scholar 

  18. Ehrenstein MR, Cook HT, Neuberger MS (2000) Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med 191:1253–1258

    Article  PubMed  CAS  Google Scholar 

  19. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM (1998) The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 5:551–562

    Article  PubMed  CAS  Google Scholar 

  20. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405:85–90

    Article  PubMed  CAS  Google Scholar 

  21. Gaipl US, Kuenkele S, Voll RE, Beyer TD, Kolowos W, Heyder P, Kalden JR, Herrmann M (2001) Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ 8:327–334

    Article  PubMed  CAS  Google Scholar 

  22. Gaipl US, Brunner J, Beyer TD, Voll RE, Kalden JR, Herrmann M (2003) Disposal of dying cells: a balancing act between infection and autoimmunity. Arthritis Rheum 48:6–11

    Article  PubMed  CAS  Google Scholar 

  23. Gaipl US, Beyer TD, Heyder P, Kuenkele S, Bottcher A, Voll RE, Kalden JR, Herrmann M (2004) Cooperation between C1q andDNase I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum 50:640–649

    Article  PubMed  CAS  Google Scholar 

  24. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, Nagata S (2004) Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304:1147–1150

    Article  PubMed  CAS  Google Scholar 

  25. Hart SP, Smith JR, Dransfield I (2004) Phagocytosis of opsonized apoptotic cells: roles for ‘old-fashioned’ receptors for antibody and complement. Clin Exp Immunol 135:181–185

    Article  PubMed  CAS  Google Scholar 

  26. Heinen E, Radoux D, Kinet-Denoel C, Moeremans M, De Mey J, Simar LJ (1985) Isolation of follicular dendritic cells from human tonsils and adenoids. III. Analysis of their Fc receptors. Immunology 54:777–784

    PubMed  CAS  Google Scholar 

  27. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cellmaterial bymonocyte-derivedmacrophages frompatients with systemic lupus erythematosus. Arthritis Rheum 41:1241–1250

    Article  PubMed  CAS  Google Scholar 

  28. Hirt UA, Leist M (2003) Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ 10:1156–1164

    Article  PubMed  CAS  Google Scholar 

  29. Janeway CA (1999) Immunobiology the immune system in health and disease. Current Biology Publications, New York, pp 339–358, 433–434

    Google Scholar 

  30. Kimberly RP, Meryhew NL, Runquist OA (1986) Mononuclear phagocyte function in SLE. I. Bipartite Fc-and complement-dependent dysfunction. J Immunol 137:91–96

    PubMed  CAS  Google Scholar 

  31. Korb LC, Ahearn JM (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158:4525–4528

    PubMed  CAS  Google Scholar 

  32. Krahling S, Callahan MK, Williamson P, Schlegel RA (1999) Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ 6:183–189

    Article  PubMed  CAS  Google Scholar 

  33. Kuijpers TW, Maianski NA, Tool AT, Becker K, Plecko B, Valianpour F, Wanders RJ, Pereira R, Van Hove J, Verhoeven AJ, Roos D, Baas F, Barth PG (2004) Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood 5:5

    Google Scholar 

  34. Kunisaki Y, Masuko S, Noda M, Inayoshi A, Sanui T, Harada M, Sasazuki T, Fukui Y (2004) Defective fetal liver erythropoiesis and T lymphopoiesis in mice lacking the phosphatidylserine receptor. Blood 103:3362–3364

    Article  PubMed  CAS  Google Scholar 

  35. Li MO, Sarkisian MR, Mehal WZ, Rakic P, Flavell RA (2003) Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302:1560–1563

    Article  PubMed  CAS  Google Scholar 

  36. Lieberthal W, Levine JS (1996) Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol 271:F477–F488

    PubMed  CAS  Google Scholar 

  37. Lorenz HM, Grunke M, Hieronymus T, Herrmann M, Kuhnel A, Manger B, Kalden JR (1997) In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 40:306–317

    PubMed  CAS  Google Scholar 

  38. Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR (2000) Role of apoptosis in autoimmunity. Apoptosis 5:443–449

    Article  PubMed  CAS  Google Scholar 

  39. Macanovic M, Lachmann PJ (1997) Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay. Clin Exp Immunol 108:220–226

    Article  PubMed  CAS  Google Scholar 

  40. Marguet D (1999) Engulfment of apoptotic cells involves the redistribution of membrane phosphatidylserine on phagocyte and prey. [Record supplied by publisher]. Nat Cell Biol 1:454–456

    Article  PubMed  CAS  Google Scholar 

  41. Marteau F, Communi D, Boeynaems JM, Suarez Gonzalez N (2004) Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on humanmonocyte-derived dendritic cells. J Leukoc Biol 76:796–803

    Article  PubMed  CAS  Google Scholar 

  42. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB (1998) Complementdependent clearance of apoptotic cells by human macrophages. J Exp Med 188:2313–2320

    Article  PubMed  CAS  Google Scholar 

  43. Mevorach D, Zhou JL, Song X, Elkon KB (1998) Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188:387–392

    Article  PubMed  CAS  Google Scholar 

  44. Moudgil KD, Sercarz EE, Grewal IS (1998) Modulation of the immunogenicity of antigenic determinants by their flanking residues. Immunol Today 19:217–220

    Article  PubMed  CAS  Google Scholar 

  45. Moudgil KD, Southwood S, Ametani A, Kim K, Sette A, Sercarz EE (1999) The self-directed T cell repertoire against mouse lysozyme reflects the influence of the hierarchy of its own determinants and can be engaged by a foreign lysozyme. J Immunol 163:4232–4237

    PubMed  CAS  Google Scholar 

  46. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181

    Article  PubMed  CAS  Google Scholar 

  47. Napirei M, Wulf S, Mannherz HG (2004) Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system. Arthritis Rheum 50:1873–1883

    Article  PubMed  CAS  Google Scholar 

  48. Pepys MB, Lanham JG, De Beer FC (1982) C-reactive protein in SLE. Clin Rheum Dis 8:91–103

    PubMed  CAS  Google Scholar 

  49. Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M (1998) High levels of circulating early apoptotic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 7:113–118

    Article  PubMed  CAS  Google Scholar 

  50. Quartier P, Potter PK, Ehrenstein MR, Walport MJ, Botto M (2004) Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells bymurine bone marrow-derived macrophages in vitro. Eur J Immunol 35:252–260

    Article  CAS  Google Scholar 

  51. Raptis L, Menard HA (1980) Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest 66:1391–1399

    PubMed  CAS  Google Scholar 

  52. Renaudineau Y, Pers JO, Bendaoud B, Jamin C, Youinou P (2004) Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev 3: 516–523

    Article  PubMed  CAS  Google Scholar 

  53. Rosen A, Casciola-Rosen L, Ahearn J (1995) Novel packages of viral and selfantigens are generated during apoptosis. J Exp Med 181:1557–1561

    Article  PubMed  CAS  Google Scholar 

  54. Rosen A, Casciola-Rosen L (1999) Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 6:6–12

    Article  PubMed  CAS  Google Scholar 

  55. Rovere P, Peri G, Fazzini F, Bottazzi B, Doni A, Bondanza A, Zimmermann VS, Garlanda C, Fascio U, Sabbadini MG, Rugarli C, Mantovani A, Manfredi AA(2000) The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 96:4300–4306

    PubMed  CAS  Google Scholar 

  56. Russell AI, Cunninghame Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J, Powell RJ, Isenberg DA, Walport MJ, Vyse TJ (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13:137–147

    Article  PubMed  CAS  Google Scholar 

  57. Salmon JE, Kimberly RP, Gibofsky A, Fotino M (1984) Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptorligand binding and internalization. J Immunol 133:2525–2531

    PubMed  CAS  Google Scholar 

  58. Savill J (1997) Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 53:491–508

    PubMed  CAS  Google Scholar 

  59. Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2:965–975

    Article  PubMed  CAS  Google Scholar 

  60. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191–195

    Article  PubMed  CAS  Google Scholar 

  61. Schagat TL, Wofford JA, Wright JR (2001) Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J Immunol 166:2727–2733

    PubMed  CAS  Google Scholar 

  62. Steinman CR (1984) Circulating DNA in systemic lupus erythematosus. Isolation and characterization. J Clin Invest 73:832–841

    PubMed  CAS  Google Scholar 

  63. Suzuki N, Harada T, Mizushima Y, Sakane T (1993) Possible pathogenic role of cationic anti-DNAautoantibodies in the development of nephritis in patientswith systemic lupus erythematosus. J Immunol 151:1128–1136

    PubMed  CAS  Google Scholar 

  64. Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC, Savill JS, Henson PM, Botto M, Walport MJ (2000) A hierarchical role for classical pathway complementproteins in the clearance of apoptotic cells in vivo. J Exp Med 192:359–366

    Article  PubMed  CAS  Google Scholar 

  65. Vandivier RW, Ogden CA, Fadok VA, Hoffmann PR, Brown KK, Botto M, Walport MJ, Fisher JH, Henson PM, Greene KE (2002) Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol 169:3978–3986

    PubMed  CAS  Google Scholar 

  66. Vigushin DM, Pepys MB, Hawkins PN (1993) Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 91:1351–1357

    Article  PubMed  CAS  Google Scholar 

  67. Volanakis JE (2001) Human C-reactive protein: expression, structure, and function. Mol Immunol 38:189–197

    Article  PubMed  CAS  Google Scholar 

  68. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I (1997) Immunosuppressive effects of apoptotic cells. Nature 390:350–351

    Article  PubMed  CAS  Google Scholar 

  69. Walker NI, Harmon BV, Gobe GC, Kerr JF (1988) Patterns of cell death. Methods Achiev Exp Pathol 13:18–54

    PubMed  CAS  Google Scholar 

  70. Walport MJ (2000) Lupus, DNase and defective disposal of cellular debris. Nat Genet 25:135–136

    Article  PubMed  CAS  Google Scholar 

  71. Winkler TH, Kalden JR (1994) Origin of anti-DNA autoantibodies in SLE. Lupus 3:75–76

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gaipl, U.S. et al. (2006). Inefficient Clearance of Dying Cells and Autoreactivity. In: Radbruch, A., Lipsky, P.E. (eds) Current Concepts in Autoimmunity and Chronic Inflammation. Current Topics in Microbiology and Immunology, vol 305. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-29714-6_8

Download citation

Publish with us

Policies and ethics